Expanded Access to Arbli™ for Hypertension
Expanded Coverage Reaches Over 100 Million Lives Across the U.S.
SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), is excited to announce significant progress in the availability of Arbli™ (losartan potassium) Oral Suspension. This innovative medication has recently been included in the formularies of several major national health plans, marking a crucial step in expanding patient access to effective treatments for hypertension.
With over 100 million lives now benefiting from this addition, Arbli™ represents a breakthrough in how patients can manage their health. This easy-to-use oral suspension formulation breaks barriers for individuals who prefer a liquid medication over pills, making treatment simpler and more accessible for everyone involved.
Arbli™, the first FDA-approved liquid formulation of losartan potassium, addresses the needs of patients who find it challenging to use solid dosage forms. The commitment SCIENTURE has shown toward enhancing patient care is commendable, as this medication not only offers a safe therapeutic option but is also designed with the patients' convenience in mind. The U.S. market for losartan itself is valued at around $256 million, highlighting the vital role of products like Arbli™ in the medication landscape.
Patient-Centric Perspectives on Arbli™
According to Narasimhan Mani, President and co-CEO of SCIENTURE, this formulary inclusion signals strong confidence from health plans in Arbli™ and the company’s products. "This is a real win for patients who deserve accessible and affordable treatment options. Health plans are now enabling better access to our medication, ensuring lower out-of-pocket costs for those enrolled," he stated.
Shankar Hariharan, Executive Chairman, and co-CEO added, "This step shows our commitment to improving health outcomes while aiming for sustainable growth. We are just beginning to pave the way for more patients across the country to access SCIENTURE’s range of products." Such affirmations resonate deeply within the healthcare community, as they underscore the emphasis on patient needs and improved health outcomes.
What Makes Arbli™ Unique?
Arbli™ stands out in the pharmaceutical market as a novel formulation of losartan. Unlike traditional solid forms, it is a ready-to-use oral suspension that eliminates the need for compounding, thus providing greater consistency in dosing and quality. The unique peppermint flavor adds an appealing touch for patients, making regular medication adherence easier. Plus, it boasts a shelf life of 24 months when stored at room temperature, making it practical for consumers.
Indications and Benefits
Arbli™ is recognized for its effectiveness in treating several conditions related to hypertension. These include:
- Managing hypertension in adults and children older than six years, significantly lowering blood pressure and reducing the risk of cardiovascular events.
- Reducing stroke risk in patients with hypertension who have left ventricular hypertrophy.
- Addressing diabetic nephropathy in patients with hypertension and type 2 diabetes, enhancing not just treatment success but overall patient health.
Understanding Hypertension
Hypertension is a severe public health issue, affecting nearly half of U.S. adults. As one of the leading causes of cardiovascular diseases, it’s essential for individuals to manage their blood pressure effectively. Symptoms can often go unnoticed, making routine check-ups crucial. Factors contributing to high blood pressure include age, obesity, a sedentary lifestyle, and high sodium intake. With effective treatments like Arbli™, managing these risks becomes significantly more achievable.
Company Overview and Contact Information
SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) operates through its subsidiary, Scienture, LLC. The company specializes in developing pharmaceutical products that aim to fulfill unmet patient needs. SCIENTURE's dynamic approach combines innovation with commitment to enhanced healthcare solutions, which is especially evidenced by the launch of Arbli™.
For more information about their products and initiatives, you can reach SCIENTURE at:
SCIENTURE HOLDINGS, INC.
20 Austin Blvd
Commack, NY 11725
Phone: (866) 468-6535
Email: IR@Scienture.com
Frequently Asked Questions
What is Arbli™?
Arbli™ is a novel oral suspension of losartan potassium designed to provide an effective treatment for hypertension.
Who can use Arbli™?
Arbli™ is indicated for patients over six years old for managing hypertension and related conditions.
What sets Arbli™ apart from other hypertension medications?
It is the first FDA-approved liquid formulation of losartan that does not require compounding, making dosing easier and more reliable.
How does SCIENTURE plan to expand access to its medications?
SCIENTURE is focused on partnerships with healthcare providers and payors to enhance treatment access and affordability for patients.
How should Arbli™ be stored?
Arbli™ can be stored at room temperature and has a shelf life of 24 months from the manufacturing date.
